Cardiogen-82 generator von radionukliden 스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

cardiogen-82 generator von radionukliden

bracco suisse sa - strontium (82-sr) la calibrazione data - generator von radionukliden - strontium (82-sr) la calibrazione data 3.3-5.6 gbq, stanni(iv) oxidum, natrii chloridi solutio 9 g/l natrii hydroxidum, acidum hydrochloridum, pro vitro, natrium mg. - für pet - (positronen-emissions-tomographie) myokardinfarkt - generator

Retsevmo 유럽 연합 - 독일어 - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastische mittel - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Sunitinib Accord 유럽 연합 - 독일어 - EMA (European Medicines Agency)

sunitinib accord

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.